Found 0 matching trials
Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
University of Alabama at Birmingham Comprehensive Cancer Center
Learn More & Join Trial
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract PHASE2 Following radical nephrectomy (RNU) for upper tract urothelial carcinoma (U...
Show More Location
Hôpital Bichat-Claude Bernard
Learn More & Join Trial
MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer PHASE3 The purpose of this study is to evaluate the addition of cisplatin to first...
Show More Location
Ospedale Villa Scassi
Learn More & Join Trial
BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer PHASE1 An open-label, uncontrolled, multicenter phase I/Ib trial to investigate sa...
Show More Location
I. Medizinische Klinik und Poliklinik der Universitätsmedizin
Learn More & Join Trial
Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) PHASE2 This study will look at the safety and efficacy of treating advanced hepato...
Show More Learn More & Join Trial
Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer PHASE3 Patients will be randomized in 1:1 ratio to two treatment groups first grou...
Show More Learn More & Join Trial
Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV PHASE2 The primary objective of this randomized phase II study is to compare the R...
Show More Location
National Cancer Center, Korea
Learn More & Join Trial
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC PHASE3 Preoperative chemotherapy is considered to play a role in early stage non s...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST) or speak with your personal physician.
Learn More & Join Trial
Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision PHASE2 The purpose of this study is to investigate if the investigators can use a ...
Show More Location
Emory University Hospital Midtown
Learn More & Join Trial
EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma PHASE2 Nearly all undifferentiated nasopharyngeal carcinoma (NPC) are associated w...
Show More Location
Sun Yat-sen Universitty Cancer Center
Learn More & Join Trial